$4.17
00.00%
Pre-Market: 5:28 PM EDT
15 minutes delayed
Adaptive Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adaptive Biotechnologies using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.31 | $-0.33 | 6.06 % |
Mar 2024 | 2024-05-07 | $-0.33 | $-0.34 | 2.94 % |
Dec 2023 | 2024-02-14 | $-0.30 | $-0.30 | 0.00 % |
Sep 2023 | 2023-11-09 | $-0.35 | $-0.34 | -2.94 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $43.19M | $38.66M | 11.7 % |
Mar 2024 | 2024-05-07 | $41.87M | $38.78M | 7.98 % |
Dec 2023 | 2024-02-14 | $45.78M | $48.46M | -5.52 % |
Sep 2023 | 2023-11-09 | $37.92M | $42.96M | -11.7 % |
Adaptive Biotechnologies (ADPT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.31, which beat the estimate of $-0.33.
The Actual Revenue was $43.2M, which beat the estimate of $38.7M.
Browse earnings estimates, EPS, and revenue on all stocks.